Hand holding the newspaper resting on a table with a cup of coffee

Newsroom

About Newsroom

The Latest News From the Ivy Center

The Ivy Brain Tumor Center at Barrow Neurological Institute strives to be a valuable resource for any brain tumor or brain cancer-related media needs. Our media relations team is happy to help answer questions and arrange interviews. The expert neurosurgeons, neuro-oncologists and scientists at the Ivy Center are available to speak on a variety of topics. 

Our state-of-the-art media studio is available for audio and video interviews. We can also arrange filming opportunities at various locations around the center and labs. 

To contact the media relation team, call Melinda Langdon at 623-297-1317 or email: [email protected]. 

Please see below for the latest media coverage and news from the Ivy Center. To read about our inspiring patients and those behind the scenes at the Ivy Center, visit the Ivy Blog. 

Taxonomy Icon
Ivy Brain Tumor Center Implements New Liquid Biopsy Program to Provide Glioblastoma Patients More Personalized Care
  • September 7, 2022
The Ivy Brain Tumor Center announced its initiation of a ‘Liquid Biopsy’ program to obtain real-time insights into how a patient’s brain tumor is responding to experimental treatment. 
Taxonomy Icon
Brain Tumors, Drug Development and Neurosurgeons: Ending the Losing Streak
  • September 6, 2022
In this Neurosurgery Blog Tumor Series, Dr. Nader Sanai, director of the Ivy Brain Tumor Center, discusses the unique challenges for brain tumor drug development and how the Ivy Center's Phase 0 clinical trials are creating a new paradigm.
Taxonomy Icon
Team at Ivy Brain Tumor Center works to cure ‘deadliest cancer in humans’
  • August 25, 2022
  • Source: ABC15
Dr. Nader Sanai spoke with local news station, ABC15 about new developments in brain cancer research and treatment on the fourth anniversary of Senator John McCain's death.
Taxonomy Icon
Ivy Brain Tumor Center discusses forms of treatment for rare aggressive brain cancer
  • August 25, 2022
  • Source: AZFamily
Dr. Kelly Braun from the Ivy Brain Tumor Center at Barrow Neurological Institute spoke with Good Morning Arizona reporter Tess Rafols, about new developments and treatments for brain cancer.
Taxonomy Icon
Glioblastoma: are Phase 0 trials a window of opportunity in drug development?
  • July 21, 2022
  • Source: Clinical Trials Arena
The Ivy Center's Phase 0 clinical trials provide valuable data on experimental drugs used to treat brain cancer. Chief Operating Officer and Deputy Director of the Ivy Center, Shwetal Mehta, was featured in Clinical Trials Arena discussing how the Ivy Center is at the forefront of this innovative brain cancer research.
Taxonomy Icon
Ivy Brain Tumor Center Announces Launch of Spanish-Language Website
  • June 15, 2022
Ivy Brain Tumor Center has launched a new Spanish-language website, providing information and resources about brain cancer for Spanish-speaking communities. Check it out now.
Taxonomy Icon
Arizona man bikes cross country for brain cancer awareness
  • May 6, 2022
  • Source: 12News
Dr. Joe Tedesco is taking the country by storm as he sets out to ride his bike from coast to coast in honor of brain tumor survivor Nate Tomlin. Covered by 12 News, Dr. Tedesco's fundraiser is gaining traction and he has increased his goal to $20,000! Check out the full story!
Taxonomy Icon
Our Bioscience Economy
  • April 9, 2022
  • Source: Greater Phoenix inBusiness
The Ivy Brain Tumor Center was recognized in a cover story by Greater Phoenix InBusiness as a top-ranked healthcare organization that provides top-notch care, innovation, and research excellence. Learn more -->
Taxonomy Icon
Our Bioscience Economy
  • April 1, 2022
  • Source: InBusiness Phoenix Magazine
InBusiness Phoenix Magazine's latest cover story they detail the Ivy Brain Tumor Center as one of the "top-ranked healthcare organizations that provide top-notch care, are innovative and known for research excellence.”
Taxonomy Icon
Ivy Brain Tumor Center Evaluates AZD1390 in Patients Diagnosed with Recurrent Grade IV Gliomas
  • March 20, 2022
  • Source: Onco'Zine
A research team at the Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer, will evaluate AZD1390 in a Phase 0/1b clinical trial with patients diagnosed with recurrent grade IV gliomas. Onco'Zine covers the full trial and provides more details in this article.